Immunotherapy showed promising antileukemia activity in pediatric patients
Sunday, April 7, 2013 - 10:30
in Health & Medicine
Researchers using patients' own immune cells in an immunotherapy approach called "anti-CD19 chimeric antigen receptor (CAR) T-cell therapy," achieved responses in children whose acute lymphocytic leukemia (ALL) had returned after a bone marrow transplant, according to preliminary results.